Pediatrics

>

Latest News

Dupilumab is Safe and Effective Across Pediatric Populations with Severe Atopic Dermatitis: New Meta-Analysis
Dupilumab is Safe and Effective Across Pediatric Populations with Severe Atopic Dermatitis: New Meta-Analysis

March 31st 2025

Dupilumab significantly improved measures of severe AD, including EASI and IGA, as well as pruritis in pediatric populations aged 6 months to 18 years vs placebo.

Pediatric Fentanyl Poisonings Spiral Up 1,200% Over 8 Years, Study Finds
Pediatric Fentanyl Poisonings Spiral Up 1,200% Over 8 Years, Study Finds

March 28th 2025

Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis / image credit ©tashatuvango/stock.adobe.com
Antibiotics, NSAIDs Reported Most Common Cause of Pediatric Anaphylaxis

March 18th 2025

Measles Outbreak Explained: Disease History, Vaccine Breakthrough and 2025 Resurgence
Measles Outbreak Explained: Disease History, Vaccine Breakthrough and 2025 Resurgence

February 27th 2025

Zonisamide Shows Promise for Hard-to-Treat Migraine in Children, Adolescents / image credit ©Lightspring/shutterstock.com
Zonisamide Shows Promise for Hard-to-Treat Migraine in Children, Adolescents

February 27th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.